PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-4.30%
Revenue decline while MCHP shows 9.00% growth. Joel Greenblatt would examine competitive position erosion.
-4.38%
Cost reduction while MCHP shows 6.93% growth. Joel Greenblatt would examine competitive advantage.
-4.22%
Gross profit decline while MCHP shows 10.89% growth. Joel Greenblatt would examine competitive position.
0.09%
Margin expansion below 50% of MCHP's 1.74%. Michael Burry would check for structural issues.
-17.26%
R&D reduction while MCHP shows 2.90% growth. Joel Greenblatt would examine competitive risk.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-14.60%
Operating expenses reduction while MCHP shows 6.58% growth. Joel Greenblatt would examine advantage.
-7.97%
Total costs reduction while MCHP shows 6.81% growth. Joel Greenblatt would examine advantage.
No Data
No Data available this quarter, please select a different quarter.
51.50%
D&A growth above 1.5x MCHP's 25.85%. Michael Burry would check for excessive investment.
1060.00%
EBITDA growth exceeding 1.5x MCHP's 18.16%. David Dodd would verify competitive advantages.
1103.17%
EBITDA margin growth exceeding 1.5x MCHP's 8.40%. David Dodd would verify competitive advantages.
15.09%
Similar operating income growth to MCHP's 14.71%. Walter Schloss would investigate industry trends.
20.27%
Operating margin growth exceeding 1.5x MCHP's 5.24%. David Dodd would verify competitive advantages.
-53.10%
Other expenses reduction while MCHP shows 89.24% growth. Joel Greenblatt would examine advantage.
-19.57%
Pre-tax income decline while MCHP shows 15.63% growth. Joel Greenblatt would examine position.
-15.96%
Pre-tax margin decline while MCHP shows 6.08% growth. Joel Greenblatt would examine position.
-48.62%
Tax expense reduction while MCHP shows 15.63% growth. Joel Greenblatt would examine advantage.
-6.77%
Net income decline while MCHP shows 15.63% growth. Joel Greenblatt would examine position.
-2.58%
Net margin decline while MCHP shows 6.08% growth. Joel Greenblatt would examine position.
-2.56%
EPS decline while MCHP shows 10.67% growth. Joel Greenblatt would examine position.
-2.63%
Diluted EPS decline while MCHP shows 21.10% growth. Joel Greenblatt would examine position.
0.73%
Share count reduction exceeding 1.5x MCHP's 3.28%. David Dodd would verify capital allocation.
17.08%
Diluted share increase while MCHP reduces shares. John Neff would investigate differences.